Amanote Research
Register
Sign In
Biologic Characteristics of Acute Leukemia After Myelodysplastic Syndrome
Blood
- United States
doi 10.1182/blood.v81.12.3388.3388
Full Text
Open PDF
Abstract
Available in
full text
Categories
Biochemistry
Immunology
Cell Biology
Hematology
Date
June 15, 1993
Authors
M Masuya
K Kita
N Shimizu
K Ohishi
N Katayama
T Sekine
A Otsuji
H Miwa
S Shirakawa
Publisher
American Society of Hematology
Related search
Leukemia-Associated Inhibitory Activity in Acute Leukemia Developed From Myelodysplastic Syndrome.
Japanese Journal of Medicine
WT1 and GATA1 Expression in Myelodysplastic Syndrome and Acute Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Secondary Philadelphia Chromosome Acquired During Therapy of Acute Leukemia and Myelodysplastic Syndrome
Modern Pathology
Forensic Medicine
Pathology
Therapy-Related Myelodysplastic Syndrome-Acute Myelogenous Leukemia in Patients Treated for Acute Promyelocytic Leukemia: An Emerging Problem
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Myelodysplastic Syndrome, Juvenile Myelomonocytic Leukemia, and Acute Myeloid Leukemia Associated With Complete or Partial Monosomy 7
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Autologous Stem Cell Transplantation for Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome
Bone Marrow Transplantation
Transplantation
Hematology
Acute Myeloid Leukemia After Myelodysplastic Syndrome and Failure of Therapy With Hypomethylating Agents: An Emerging Entity With a Poor Prognosis
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Combinatorial Haplo-Deficient Tumor Suppression in 7q-Deficient Myelodysplastic Syndrome and Acute Myeloid Leukemia
Cancer Cell
Cancer Research
Oncology
Cell Biology
Sequential Allogeneic Stem Cell Transplantation in High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
